{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T23:02:26Z","timestamp":1648681346948},"reference-count":15,"publisher":"Japanese Society of Internal Medicine","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2018]]},"DOI":"10.2169\/internalmedicine.9291-17","type":"journal-article","created":{"date-parts":[[2017,10,31]],"date-time":"2017-10-31T18:12:31Z","timestamp":1509473551000},"page":"265-268","source":"Crossref","is-referenced-by-count":0,"title":["Myasthenic Crisis Complicated with Myxedema, Positive for Both Anti-acetylcholine Receptor and Anti-muscle-specific Tyrosine Kinase Antibodies"],"prefix":"10.2169","volume":"57","author":[{"given":"Kazuhiro","family":"Horiuchi","sequence":"first","affiliation":[{"name":"Department of Neurology, Obihiro Kosei General Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Azusa","family":"Nagai","sequence":"additional","affiliation":[{"name":"Department of Neurology, Obihiro Kosei General Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"Wakita","sequence":"additional","affiliation":[{"name":"Department of Neurology, Obihiro Kosei General Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shotaro","family":"Ito","sequence":"additional","affiliation":[{"name":"First Department of Medicine, Obihiro Kosei General Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kei","family":"Takamura","sequence":"additional","affiliation":[{"name":"First Department of Medicine, Obihiro Kosei General Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideki","family":"Houzen","sequence":"additional","affiliation":[{"name":"Department of Neurology, Obihiro Kosei General Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Kanazawa M, Shimohata T, Tanaka K, Nishizawa M. Clinical features of patients with myasthenia gravis associated with autoimmune diseases. Eur J Neurol 14: 1403-1404, 2007.","DOI":"10.1111\/j.1468-1331.2007.01978.x"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Kubiszewska J, Szyluk B, Szczudlik P, et al. Prevalence and impact of autoimmune thyroid disease on myasthenia gravis course. Brain Behav 6: e00537, 2016.","DOI":"10.1002\/brb3.537"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Klubo-Gwiezdzinska J, Wartofsky L. Thyroid emergencies. Med Clin North Am 96: 385-403, 2012.","DOI":"10.1016\/j.mcna.2012.01.015"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Salomo LH, Laursen AH, Reiter N, Feldt-Rasmussen U. Myxoedema coma: an almost forgotten, yet still existing cause of multiorgan failure. BMJ Case Reports: 2014.","DOI":"10.1136\/bcr-2013-203223"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Lacomis D. Myasthenic crisis. Neurocrit Care 3: 189-194, 2005.","DOI":"10.1385\/NCC:3:3:189"},{"key":"6","unstructured":"6. Wall CR. Myxedema coma: diagnosis and treatment. Am Fam Physician 62: 2485-2490, 2000."},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Yeh JH, Chen WH, Chiu HC, Bai CH. MuSK antibody clearance during serial sessions of plasmapheresis for myasthenia gravis. J Neurol Sci 263: 191-193, 2007.","DOI":"10.1016\/j.jns.2007.05.033"},{"key":"8","first-page":"510","volume":"45","author":"H Suzuki","year":"2005","unstructured":"8. Suzuki H, Motomura M, Yoshimura T, et al. A case of myasthenia gravis with anti-MuSK antibodies showing a dramatic improvement with plasma exchange. Rinsho Shinkeigaku 45: 510-513, 2005 (in Japanese, Abstract in English).","journal-title":"Rinsho Shinkeigaku","ISSN":"http:\/\/id.crossref.org\/issn\/0009-918X","issn-type":"print"},{"key":"9","doi-asserted-by":"publisher","unstructured":"9. Evoli A, Tonali PA, Padua L, et al. Clinical correlates with anti-MuSK antibodies in generalized seronegative myasthenia gravis. Brain 126: 2304-2311, 2003.","DOI":"10.1093\/brain\/awg223"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Fern\u00e1ndez JA, Fern\u00e1ndez-Vali\u00f1as A, Hern\u00e1ndez D, Orozco J, Lugo A. Myasthenic crisis in an elderly patient with positive antibodies against acetylcholine and anti-MuSK, successfully treated with noninvasive mechanical ventilation. Case Rep Crit Care 2015: 624718, 2015.","DOI":"10.1155\/2015\/624718"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Saulat B, Maertens P, Hamilton WJ, Bassam BA. Anti-musk antibody after thymectomy in a previously seropositive myasthenic child. Neurology 69: 803-804, 2007.","DOI":"10.1212\/01.wnl.0000267694.45244.f4"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Kostera-Pruszczyk A, Kwiecinski H. Juvenile seropositive myasthenia gravis with anti-MuSK antibody after thymectomy. J Neurol 256: 1780-1781, 2009.","DOI":"10.1007\/s00415-009-5215-2"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Rajakulendran S, Viegas S, Spillane J, Howard RS. Clinically biphasic myasthenia gravis with both AChR and MuSK antibodies. J Neurol 259: 2736-2739, 2012.","DOI":"10.1007\/s00415-012-6661-9"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Poulas K, Koutsouraki E, Kordas G, Kokla A, Tzartos SJ. Anti-MuSK- and anti-AChR-positive myasthenia gravis induced by d-penicillamine. J Neuroimmunol 250: 94-98, 2012.","DOI":"10.1016\/j.jneuroim.2012.05.011"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Wolfe GI, Kaminski HJ, Aban IB, et al. Randomized trial of thymectomy in myasthenia gravis. N Engl J Med 375: 511-522, 2016.","DOI":"10.1056\/NEJMc1611704"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/57\/2\/57_9291-17\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,5]],"date-time":"2019-10-05T07:48:23Z","timestamp":1570261703000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/57\/2\/57_9291-17\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"references-count":15,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.9291-17","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018]]}}}